U.S. Regulator Reiterates Concerns About Dr. Reddy’s Telangana Plant
Workers check automatic packaging of medicine tablets manufactured at Dr. Reddy’s plant at Bachupally in Telangana. (Photographer: Amit Bhargava/Bloomberg News)

U.S. Regulator Reiterates Concerns About Dr. Reddy’s Telangana Plant

Shares of Dr. Reddy's Laboratories Ltd. tumbled as much as 29.78 percent, the most in more than 17 years, as the U.S. drug regulator reiterated issues regarding manufacturing standards at its plant...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.